Literature DB >> 7516927

Regulation of ICAM-1 (CD54) expression in human breast cancer cell lines by interleukin 6 and fibroblast-derived factors.

D Hutchins1, C M Steel.   

Abstract

Four human breast cancer cell lines (T47D, ZR-75-1, MCF7D and HS578T) were examined for the effects of cytokines on expression of cell surface antigens. Interferon (IFN)gamma up-regulated the expression of ICAM-I (CD54) in all the cell lines and coordinately up-regulated both CD54 and CD40 expression in T47D. Tumour necrosis factor (TNF)alpha, interleukin (IL)1 alpha, IL1 beta and IL6 also up-regulated the expression of CD54 in all the cell lines but CD40 was unaffected. Levels of expression of CD11a, CD18, CD49b, CD58 and CD71 were unaltered by these cytokines. Conditioned medium (CM) generated from human fibroblasts, and in particular from foetal cells, was highly effective in up-regulating expression of ICAM-1 but not of CD40 in the breast cancer cell lines. ICAM-1 induction correlated with IL6 bioactivity in these CMs. Combinations of IL6 with other cytokines, such as IL1, resulted in further increases in ICAM-1 expression. Our observations suggest that IL6 is involved in intercellular signalling between mesenchyme and breast cancer epithelium.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7516927     DOI: 10.1002/ijc.2910580114

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  14 in total

1.  Expressions of ICAM-1 and its mRNA in sera and tissues of patients with hepatocellular carcinoma.

Authors:  J Xu; M H Mei; S E Zeng; Q F Shi; Y M Liu; L L Qin
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

2.  Relation between common polymorphisms in genes related to inflammatory response and colorectal cancer.

Authors:  George Theodoropoulos; Ioannis Papaconstantinou; Evangelos Felekouras; Nikolaos Nikiteas; Petros Karakitsos; Dimitris Panoussopoulos; Andreas Ch Lazaris; Efstratios Patsouris; John Bramis; Maria Gazouli
Journal:  World J Gastroenterol       Date:  2006-08-21       Impact factor: 5.742

3.  Intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and regulated on activation normal T cell expressed and secreted are expressed by human breast carcinoma cells and support eosinophil adhesion and activation.

Authors:  S Ali; J Kaur; K D Patel
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

4.  Prognostic value of intercellular adhesion molecule (ICAM)-1 expression in breast cancer.

Authors:  Christine Schröder; Isabell Witzel; Volkmar Müller; Sylke Krenkel; Ralph M Wirtz; Fritz Jänicke; Udo Schumacher; Karin Milde-Langosch
Journal:  J Cancer Res Clin Oncol       Date:  2011-05-18       Impact factor: 4.553

5.  CD40 is a prognostic marker in primary cutaneous malignant melanoma.

Authors:  J J van den Oord; A Maes; M Stas; J Nuyts; S Battocchio; A Kasran; M Garmyn; I De Wever; C De Wolf-Peeters
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

Review 6.  Inflammatory signaling and cellular senescence.

Authors:  Jian-Lin Ren; Jin-Shui Pan; Ya-Pi Lu; Peiqing Sun; Jiahuai Han
Journal:  Cell Signal       Date:  2008-10-26       Impact factor: 4.315

Review 7.  New insights into tumor-host interactions in lymphoma metastasis.

Authors:  V Umansky; V Schirrmacher; M Rocha
Journal:  J Mol Med (Berl)       Date:  1996-07       Impact factor: 4.599

8.  Whole Transcriptomic Analysis of Apigenin on TNFα Immuno-activated MDA-MB-231 Breast Cancer Cells.

Authors:  David Bauer; Elizabeth Mazzio; Karam F A Soliman
Journal:  Cancer Genomics Proteomics       Date:  2019 Nov-Dec       Impact factor: 4.069

9.  Human ovarian tumor cells escape γδ T cell recognition partly by down regulating surface expression of MICA and limiting cell cycle related molecules.

Authors:  Jingwei Lu; Reeva Aggarwal; Suman Kanji; Manjusri Das; Matthew Joseph; Vincent Pompili; Hiranmoy Das
Journal:  PLoS One       Date:  2011-09-14       Impact factor: 3.240

Review 10.  CD58 Immunobiology at a Glance.

Authors:  Yalu Zhang; Qiaofei Liu; Sen Yang; Quan Liao
Journal:  Front Immunol       Date:  2021-06-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.